Fulcrum Therapeutics, Inc. Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Fulcrum Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Fulcrum Therapeutics, Inc. for July 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24 2019 | FULC | Fulcrum Therapeuti ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 12,500,000 | 0 | 0 | ||
| Jul 24 2019 | FULC | Fulcrum Therapeuti ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 1,785,714 | 0 | 1,785,714 | 0 to 1.8 M | |
| Jul 23 2019 | FULC | Fulcrum Therapeuti ... | Sanofi | 10% Owner | Option Exercise | C | 0.00 | 3,250,000 | 0 | 0 | |
| Jul 23 2019 | FULC | Fulcrum Therapeuti ... | Sanofi | 10% Owner | Buy | P | 16.00 | 93,750 | 1,500,000 | 558,035 | 464.3 K to 558 K (+20.19 %) |
| Jul 23 2019 | FULC | Fulcrum Therapeuti ... | Sanofi | 10% Owner | Buy | C | 0.00 | 464,285 | 0 | 464,285 | 0 to 464.3 K |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 15,833,333 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures IV, L.P. | 10% Owner | Buy | P | 16.00 | 81,250 | 1,300,000 | 2,343,154 | 2.3 M to 2.3 M (+3.59 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 2,261,904 | 0 | 2,261,904 | 0 to 2.3 M |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 39,166,667 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | P | 16.00 | 81,250 | 1,300,000 | 5,962,202 | 5.9 M to 6 M (+1.38 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 5,595,238 | 0 | 5,880,952 | 285.7 K to 5.9 M (+1,958.34 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | 6 Dimensions Capital, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,087,500 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | 6 Dimensions Capital, L.P. | 10% Owner | Buy | P | 16.00 | 118,750 | 1,900,000 | 559,821 | 441.1 K to 559.8 K (+26.92 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | 6 Dimensions Capital, L.P. | 10% Owner | Buy | C | 0.00 | 441,071 | 0 | 441,071 | 0 to 441.1 K |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,250,000 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | P | 14.50 | 5,000 | 72,499 | 604,285 | 599.3 K to 604.3 K (+0.83 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | P | 14.50 | 10,000 | 144,996 | 599,285 | 589.3 K to 599.3 K (+1.70 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | P | 16.00 | 125,000 | 2,000,000 | 589,285 | 464.3 K to 589.3 K (+26.92 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Casdin Capital, LLC | 10% Owner | Buy | C | 0.00 | 464,285 | 0 | 464,285 | 0 to 464.3 K |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | LEVIN MARK J | Director | Option Exercise | C | 0.00 | 39,166,667 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | LEVIN MARK J | Director | Buy | P | 16.00 | 81,250 | 1,300,000 | 5,962,202 | 5.9 M to 6 M (+1.38 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | LEVIN MARK J | Director | Buy | C | 0.00 | 5,595,238 | 0 | 5,880,952 | 285.7 K to 5.9 M (+1,958.34 %) |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Section 32 Fund 2, LP | 10% Owner | Option Exercise | C | 0.00 | 3,250,000 | 0 | 0 | |
| Jul 22 2019 | FULC | Fulcrum Therapeuti ... | Section 32 Fund 2, LP | 10% Owner | Buy | C | 0.00 | 464,285 | 0 | 464,285 | 0 to 464.3 K |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | A | 16.00 | 44,493 | 711,888 | 44,493 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Collins James J. | Director | Option Exercise | A | 16.00 | 5,714 | 91,424 | 5,714 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | GERAGHTY JAMES A | Director | Option Exercise | A | 16.00 | 9,285 | 148,560 | 9,285 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Ezekowitz Alan | Director | Option Exercise | A | 16.00 | 5,714 | 91,424 | 5,714 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Haviland Kate | Director | Option Exercise | A | 16.00 | 9,285 | 148,560 | 9,285 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Option Exercise | A | 16.00 | 107,142 | 1,714,272 | 107,142 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Cadavid Diego | See Remarks | Option Exercise | A | 16.00 | 12,784 | 204,544 | 12,784 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Stuart Bryan | Chief Operating Off ... | Option Exercise | A | 16.00 | 28,571 | 457,136 | 28,571 | |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | See Remarks | Option Exercise | A | 16.00 | 7,078 | 113,248 | 7,078 |